Efavirenz in an obese HIV-infected patient--a report and an in vitro-in vivo extrapolation model indicate risk of underdosing.

نویسندگان

  • Mirjam de Roche
  • Marco Siccardi
  • Marcel Stoeckle
  • Françoise Livio
  • David Back
  • Manuel Battegay
  • Catia Marzolini
چکیده

Here, we report suboptimal efavirenz exposure in an obese patient treated with the standard 600 mg dose. Tripling the dose allowed attainment of therapeutic efavirenz concentrations. We developed an in vitro-in vivo extrapolation model to quantify dose requirements in obese individuals. Obesity represents a risk factor for antiretroviral therapy underdosing.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Pneumonia due to Salmonella typhimuriumin an HIV-Infected Patient

HIV-related Immunosuppression significantly increases the risk of acquiring opportunistic infections. This report describes a 69-year-old man, referred to hospital with decreased consciousness and productive cough. This man was a known case of human immunodeficiency virus positive. The sputum of this patient was positive for Salmonella typhimurium. Pulmonary auscultation signaled brief...

متن کامل

Successful Desensitization Efavirenz in 8 -year-Old HIV-Positive Child

Background & Aims: Allergic reaction is a common side effect of Efavirenz and drug replacement may not be an option to physicians. Here, a successful drug desensitization experiment on an 8-year-old female child over a period of 9 days is reported. Case presentation: The patient was an 8-year old female child with HIV in Kerman, Iran who had been received oral efavirenz together with lamivudine...

متن کامل

A Case Report of Cerebral Toxoplasmosis in An HIV-Positive Patient: Risk of Possible Transmission through Contaminated Water/Food

Introduction: Toxoplasma gondii is an obligatory intracellular protozoan with a worldwide distribution. We reported here the cerebral toxoplasmosis in an Iranian HIV-positive patient. Case report: A 35-year-old woman that hospitalized at Golestan province, in summer 2016 because of dizziness, fever, and headache. After treatment, she showed severe pain and then paralysis symptoms. Magnetic res...

متن کامل

The Novel Study of IMODTM against HIV-1, P24 production

AIDS (Acquired Immune Deficiency Syndrome), a result of human HIV (Human Immunodeficinency Virus) infection, is one of the most troublesome world's health problems. Extensive researches to find effective drugs for its treatment are running fast in huge capacities. IMOD (Immuno-Modulator Drug) is the name of an herbal drug that has modulatory effects of immune system. As a goal of this research,...

متن کامل

The Prevalence and Risk Factors of Hepatitis Delta Virus in HIV/HBV Co-Infected Patients in Shiraz, Iran, 2012

Evidence has shown that liver disease caused by hepatitis viruses can be more aggressive and severe in HIV infected subjects. Therefore, the present cross-sectional study aimed to evaluate the seroprevalence of HDV infection among HIV/HBV co-infected clients in Shiraz, southwest Iran. In this study, 178 patients co-infected with HBV and HIV individuals were enrolled. The diagnosis of HIV infect...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Antiviral therapy

دوره 17 7  شماره 

صفحات  -

تاریخ انتشار 2012